New PD-L1 Inhibitor Could Make Mesothelioma Immunotherapy Safer
A new PD-L1 inhibitor may be on the horizon for people with malignant mesothelioma. A Phase I trial suggests it…
-
-
CAR-T Cells + Keytruda: New Immunotherapy for Pleural Mesothelioma?
Researchers at a top US cancer center are experimenting with a new approach to immunotherapy for pleural mesothelioma – with… -
New Studies | Prognosis | Research | Surgery | Treatments
New Test May Help Doctors Choose the Best Mesothelioma Surgery
A new predictive model may make it easier for cancer doctors to choose the best mesothelioma surgery for each pleural… -
Study May Lead to Safer Immunotherapy for Mesothelioma
New research conducted in Europe and at Harvard University may open the door to safer immunotherapy for mesothelioma patients. Immunotherapy… -
Early Data Show Promise for Galinpepimut-S and Opdivo in Mesothelioma Patients
A combination of the immunotherapy drugs galinpepimut-S and Opdivo may give mesothelioma patients a few extra months, according to newly-released… -
Chemotherapy | Europe | International | New Studies | Research | Treatments
Treatment with Vinorelbine for Relapsed Pleural Mesothelioma
A new study suggests that treatment with vinorelbine may boost progression free survival for people with relapsed malignant mesothelioma. Mesothelioma… -
Europe | Immunotherapy | International | New Drugs | New Studies | Research | Treatments
Immunotherapy Treatment ONCOS-102: News Keeps Getting Better
The news just keeps getting better for the virus-based immunotherapy treatment ONCOS-102. Norweigian drug maker Targovax recently released the final… -
Effectiveness of Keytruda: Dutch Study Offers Clues for Prediction
A new Dutch study offers some clues that might help doctors predict the effectiveness of Keytruda (pembrolizumab) in individual mesothelioma… -
Adjuvant Radiotherapy May Not Lengthen Mesothelioma Survival, Study Shows
Having adjuvant radiotherapy after surgery may not help mesothelioma patients live any longer according to researchers at Duke and Stanford… -
Breath Test Could Predict Mesothelioma Immunotherapy Response
New research shows a breath test called an eNose might help doctors determine which mesothelioma patients are most likely to…
